zepbound/mounjaro/tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide (Mounjaro & Zepbound) for

Users considering phentermine alongside tirzepatide should note that phentermine also has stimulant properties that may affect sexual function differently

Some individuals find that cold or room-temperature proteins, such as Greek yoghurt or cottage cheese, are more palatable than hot meals when experiencing nausea

They are the ones who plan ahead

The agency warned on Monday that the economic toll of obesity was rising sharply, with the annual global cost to reach $3 trillion US by 2030

Patients can remain on these medications indefinitely, and the clinical data supporting long-term use extends to multiple years

Those with prediabetes Emerging evidence suggests that GLP-1 drugs could help prevent or delay the onset of Type 2 diabetes in individuals with prediabetes by improving insulin sensitivity and promoting weight loss